Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F1W20
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,987
Award facts
- Contract value 100% obligated
- $81,986.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $81,986.97 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 mg tablets (28-count units). This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a competitively awarded non-set-aside contract with performance to be fulfilled at the contractor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen trade name), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains significant IDCs with both the DLA and other federal agencies, consistently demonstrating its capability to fulfill government requirements for essential pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26F1W20?
SPE2DR26F1W20 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1W20 worth?
The government has obligated $81,987 on SPE2DR26F1W20.
Is contract SPE2DR26F1W20 an order under another contract?
Yes. SPE2DR26F1W20 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W20 competed?
The extent of competition for SPE2DR26F1W20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award